AbbVie : ABBV

All AbbVie Articles

613 Articles

Lee Jackson | Feb 16, 2016 at 8:25 AM EST

Jefferies Has 4 Franchise Pick Dividend Stocks at Rock-Bottom Prices

One thing that the recent sell-off has accomplished is to take top companies residing in the Jefferies Franchise Picks list…

Chris Lange | Feb 10, 2016 at 9:15 AM EST

Short Sellers Increase Bets in Major Pharma

The January 29 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short…

Lee Jackson | Feb 8, 2016 at 8:25 AM EST

4 Big Dividend Pharmaceutical Stocks to Buy That Are Very Cheap Now

If you ever want to look for value in a sector in the stock market, then when you see Congress…

Chris Lange | Jan 29, 2016 at 10:45 AM EST

Investors Were Not Impressed With AbbVie Q4 Earnings

AbbVie reported mixed fourth-quarter financial results after the markets closed Thursday.

Chris Lange | Jan 28, 2016 at 1:25 PM EST

What to Look For in AbbVie Earnings

AbbVie is scheduled to report its fourth-quarter financial results before the markets open Friday.

Chris Lange | Jan 28, 2016 at 8:40 AM EST

Short Sellers Become More Selective on Major Pharma

The January 15 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short…

Lee Jackson | Jan 22, 2016 at 8:35 AM EST

4 Jefferies Growth Stocks to Buy as January Selling Presents Big Opportunity

The Wall Street firms we cover are well aware of investor anxiety, yet they, unlike financial media talking heads, realize…

Chris Lange | Jan 13, 2016 at 9:15 AM EST

Major Pharma Short Sellers Increase Bets

The short interest data have been released for the December 31 settlement date. For most of the selected pharmaceutical stocks…

Lee Jackson | Jan 11, 2016 at 8:25 AM EST

Jefferies Dividend Franchise Picks Stocks to Buy on Sale After Big Market Sell-Off

In a new research note, Jefferies makes the case that earnings could give a lift to the sagging market, and…

Chris Lange | Dec 28, 2015 at 9:35 AM EST

Major Pharma Short Interest Takes Another Giant Leap Forward

The short interest data have been released for the December 15 settlement date, and for most of the selected pharmaceutical…

Lee Jackson | Dec 23, 2015 at 8:25 AM EST

Top-Yielding Jefferies Franchise List Stocks to Buy for 2016

24/7 Wall St. screened the Jefferies Franchise Picks list for the top-yielding stocks and found four with outstanding growth potential.

Chris Lange | Dec 10, 2015 at 8:50 AM EST

Short Interest in Major Pharma Takes a Giant Leap

The November 30 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Chris Lange | Dec 7, 2015 at 4:09 PM EST

Jefferies Top Pharma Stock Picks for 2016

Brokerage firm Jefferies has released its top pharmaceutical picks for the coming year and what to expect.

Lee Jackson | Dec 4, 2015 at 9:55 AM EST

Jefferies Makes Year-End Changes to Franchise List of Stocks to Buy

The Franchise Picks list makes sense for solid growth investors looking for total return. Many of the stocks pay good…

Jon C. Ogg | Dec 1, 2015 at 8:45 AM EST

Top Analyst Upgrades and Downgrades: AbbVie, CDW, CSC, Eli Lilly, Ericsson, Gold Fields, JD.com, Nokia, Rackspace and Many More

Tuesday's top analyst upgrades, downgrades and initiations include AbbVie, CDW, CSC, Eli Lilly, Ericsson, Gold Fields, JD.com, Nokia and Rackspace.

1 … 32 33 34 35 36 … 41

AbbVie : ABBV

All AbbVie Articles

Jefferies Has 4 Franchise Pick Dividend Stocks at Rock-Bottom Prices

Short Sellers Increase Bets in Major Pharma

4 Big Dividend Pharmaceutical Stocks to Buy That Are Very Cheap Now

Investors Were Not Impressed With AbbVie Q4 Earnings

What to Look For in AbbVie Earnings

Short Sellers Become More Selective on Major Pharma

4 Jefferies Growth Stocks to Buy as January Selling Presents Big Opportunity

Major Pharma Short Sellers Increase Bets

Jefferies Dividend Franchise Picks Stocks to Buy on Sale After Big Market Sell-Off

Major Pharma Short Interest Takes Another Giant Leap Forward

Top-Yielding Jefferies Franchise List Stocks to Buy for 2016

Short Interest in Major Pharma Takes a Giant Leap

Jefferies Top Pharma Stock Picks for 2016

Jefferies Makes Year-End Changes to Franchise List of Stocks to Buy

Top Analyst Upgrades and Downgrades: AbbVie, CDW, CSC, Eli Lilly, Ericsson, Gold Fields, JD.com, Nokia, Rackspace and Many More

The Portfolio Blueprint for Building $20,000 a Month in Dividend Income

At 57, He Was Pushed Out as AI Reshaped His Field. Two Years Later, Claiming Social Security at 62 Is Tempting, and Costly.

The $1 Million Portfolio With Two Very Different Futures

Samsung Reinvented Itself by Rethinking What It's Worth. Retirees Who Do the Same Find Social Security Is Their Largest Asset.

The Portfolio Blueprint for Building $20,000 a Month in Dividend Income

Warren Buffett Says He Now Likes “Four or Five” Businesses Berkshire Owns More than Alphabet. What Are They?

Samsung Reinvented Itself by Rethinking What It’s Worth. Retirees Who Do the Same Find Social Security Is Their Largest Asset.

AbbVie : ABBV

All AbbVie Articles

Jefferies Has 4 Franchise Pick Dividend Stocks at Rock-Bottom Prices

Short Sellers Increase Bets in Major Pharma

4 Big Dividend Pharmaceutical Stocks to Buy That Are Very Cheap Now

Investors Were Not Impressed With AbbVie Q4 Earnings

What to Look For in AbbVie Earnings

Short Sellers Become More Selective on Major Pharma

4 Jefferies Growth Stocks to Buy as January Selling Presents Big Opportunity

Major Pharma Short Sellers Increase Bets

Jefferies Dividend Franchise Picks Stocks to Buy on Sale After Big Market Sell-Off

Major Pharma Short Interest Takes Another Giant Leap Forward

Top-Yielding Jefferies Franchise List Stocks to Buy for 2016

Short Interest in Major Pharma Takes a Giant Leap

Jefferies Top Pharma Stock Picks for 2016

Jefferies Makes Year-End Changes to Franchise List of Stocks to Buy

Top Analyst Upgrades and Downgrades: AbbVie, CDW, CSC, Eli Lilly, Ericsson, Gold Fields, JD.com, Nokia, Rackspace and Many More

The Portfolio Blueprint for Building $20,000 a Month in Dividend Income

At 57, He Was Pushed Out as AI Reshaped His Field. Two Years Later, Claiming Social Security at 62 Is Tempting, and Costly.

The $1 Million Portfolio With Two Very Different Futures

Featured Reads

Samsung Reinvented Itself by Rethinking What It's Worth. Retirees Who Do the Same Find Social Security Is Their Largest Asset.

The Portfolio Blueprint for Building $20,000 a Month in Dividend Income